Latest Europe News

Ovanti appoints two early Afterpay executives to its Advisory Board as it prepares to relaunch its BNPL platforms IOUPAY and myIOU, targeting rapid growth in Southeast Asia and beyond.

ECS Botanics delivered a fourth consecutive quarter of positive operating cash flow in Q4 FY26, with a full-year turnaround of $5.9 million. The company’s branded B2C revenue surged 31% year-on-year, supported by product launches and European market expansion.

Boresight Ltd has secured a lease for a new 812 square metre manufacturing hub in Huntsville, Alabama, vastly expanding its US production capacity for aerial target drones amid rising military demand.

Ava Risk Group expects FY2026 revenue around $29 million, below prior guidance, due to delayed orders mainly in the Middle East and North America. Despite this, sales intake exceeded revenue, underpinning a strong backlog and positive EBITDA.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

Volt Resources’ Ukrainian subsidiary Zavalievsky Graphite is launching a new graphite production campaign in July 2026, supported by firm European sales contracts worth around €377,000.

Phoslock Environmental Technologies increased production significantly in the June quarter but faced a higher operating cash flow deficit and ongoing legal disputes.

Starpharma launches a fully underwritten $32 million entitlement offer to fund the Phase 1 trial of its DEP® HER2-Lutetium radiopharmaceutical and accelerate its targeted oncology asset development.

Strickland Metals has increased the inferred resource at its Copper Canyon deposit in Serbia, adding nearly 300,000 ounces of gold and enhancing the Rogozna Project's standing as one of Europe's largest undeveloped gold-copper assets.

Vulcan Energy has received the first tranche of equity funding from its €2.2 billion financing package for the Lionheart lithium and geothermal project, confirming progress aligned with its construction schedule.

Vection Technologies has secured a three-year, $7.5 million framework agreement with Switzerland’s URBANnext SA to deploy its Algho AI platform across European smart city and infrastructure markets, establishing a committed revenue floor and extending its indirect sales channel.

OncoSil Medical has completed key manufacturing validation cycles with Cyclotek, paving the way for scalable Australian production of its OncoSil™ device. With a $2.1 million capital investment, the company aims to boost margins and supply chain control ahead of commercial launch in late 2026.